Worldwide prevalence of extended spectrum β-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis
Infezioni in Medicina · 01.12.2023 · 31 (4)
DOI: 10.53854/liim-3104-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infezioni in Medicina, online erschienen am 01.12.2023. Verfasst von Talieh Mostaghimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Babol University of Medical Sciences, Babol, Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A significant proportion of urinary tract infections (UTIs), typically affecting kidney transplant patients (KTPs), is attributed to the presence of extended-spectrum β-lactamases (ESBLs) and multi-drug resistance (MDR) in Escherichia coli strains. For this reason, the current meta-analysis was conducted to summarize the frequency of ESBL-producing UPEC among KTPs. A systematic search was conducted to identify studies in the Web of Science, PubMed, Embase, and Scopus electronic databases between 2000 and 2021. Finally, 16 articles were selected for data extraction, and meta-analysis was performed using the metaprop command in the STATA (version 11) software. From those studies, the pooled prevalence of ESBL-producing uropathogenic E. coli (UPEC) isolates was 40%. The subcategory analysis results based on continent indicated that Asian countries had the highest rate of ESBL-producing isolates with 45%, followed by 40%, 28%, and 16% in Europe, South America and North America, respectively. Uncomfortably, high level of UPEC isolates in the current investigation was ESBL-producing isolates. These isolates pose a high serious threat to public health because they can contribute to the spread of antimicrobial resistance in the local population and hasten the ineffectiveness of the majority of commonly prescribed antibiotics for the treatment of UTI in KTPs and other patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
- Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
- Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
- Department of Medical Microbiology and Biotechnology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Zitieren
APA
Mostaghimi, T., Shirafkan, H., Nasrollahian, S., Fayyazi, A., Hatami, M., Rajabnia, M., Pournajaf, A., & Halaji, M. (2023). Worldwide prevalence of extended spectrum β-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis. Infezioni in Medicina, 31(4). https://doi.org/10.53854/liim-3104-5
Vancouver
Mostaghimi T, Shirafkan H, Nasrollahian S, Fayyazi A, Hatami M, Rajabnia M, et al. Worldwide prevalence of extended spectrum β-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis. Infezioni in Medicina. 2023;31(4). doi:10.53854/liim-3104-5
BibTeX
@article{Mostaghimi2023,
author = {Mostaghimi, Talieh and Shirafkan, Hoda and Nasrollahian, Sina and Fayyazi, Amirhossein and Hatami, Maryam and Rajabnia, Mehdi and Pournajaf, Abazar and Halaji, Mehrdad},
title = {Worldwide prevalence of extended spectrum β-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis},
journal = {Infezioni in Medicina},
year = {2023},
volume = {31},
number = {4},
doi = {10.53854/liim-3104-5}
}
EUVIMED